Literature DB >> 27493028

Neuromuscular junctions are pathological but not denervated in two mouse models of spinal bulbar muscular atrophy.

Jessica E Poort1, Mary B Rheuben1, S Marc Breedlove1, Cynthia L Jordan2.   

Abstract

Spinal bulbar muscular atrophy (SBMA) is a progressive, late onset neuromuscular disease causing motor dysfunction in men. While the morphology of the neuromuscular junction (NMJ) is typically affected by neuromuscular disease, whether NMJs in SBMA are similarly affected by disease is not known. Such information will shed light on whether defective NMJs might contribute to the loss of motor function and represent a potential therapeutic target for treating symptoms of SBMA. To address this gap in information, the morphology of NMJs was examined in two mouse models of SBMA, a myogenic model that overexpresses wildtype androgen receptor (AR) exclusively in muscle fibres and a knockin (KI) model expressing a humanized mutant AR gene. The tripartite motor synapse consisting of motor nerve terminal, terminal Schwann cells (tSCs) and postsynaptic specialization were visualized and analysed using confocal microscopy. Counter to expectation, we found no evidence of denervation in either model, but junctions in both models show pathological fragmentation and an abnormal synaptophysin distribution consistent with functionally weak synapses. Neurofilament accumulations were observed only in the myogenic model, even though axonal transport dysfunction is characteristic of both models. The ultrastructure of NMJs revealed additional pathology, including deficits in docked vesicles presynaptically, wider synaptic clefts, and simpler secondary folds postsynaptically. The observed pathology of NMJs in diseased SBMA mice is likely the morphological correlates of defects in synaptic function which may underlie motor impairments associated with SBMA.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27493028      PMCID: PMC5216617          DOI: 10.1093/hmg/ddw222

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  67 in total

1.  Regulation of terminal Schwann cell number at the adult neuromuscular junction.

Authors:  J L Lubischer; D M Bebinger
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  Recovery of function in a myogenic mouse model of spinal bulbar muscular atrophy.

Authors:  Jamie A Johansen; Zhigang Yu; Kaiguo Mo; D Ashley Monks; Andrew P Lieberman; S Marc Breedlove; Cynthia L Jordan
Journal:  Neurobiol Dis       Date:  2008-12-31       Impact factor: 5.996

3.  Some effects of nerve stimulation andhemicholinium on quantal transmitter release at the mammalian neuromuscular junction.

Authors:  S F Jones; S Kwanbunbumpen
Journal:  J Physiol       Date:  1970-03       Impact factor: 5.182

4.  Nerve sprouting in muscle is induced and guided by processes extended by Schwann cells.

Authors:  Y J Son; W J Thompson
Journal:  Neuron       Date:  1995-01       Impact factor: 17.173

5.  Dystrophin is required for organizing large acetylcholine receptor aggregates.

Authors:  J Kong; J E Anderson
Journal:  Brain Res       Date:  1999-08-28       Impact factor: 3.252

6.  Truncated dystrophins can influence neuromuscular synapse structure.

Authors:  Glen B Banks; Jeffrey S Chamberlain; Stanley C Froehner
Journal:  Mol Cell Neurosci       Date:  2009-01-08       Impact factor: 4.314

7.  Hormonal control of neuron number in sexually dimorphic spinal nuclei of the rat: III. Differential effects of the androgen dihydrotestosterone.

Authors:  D R Sengelaub; E J Nordeen; K W Nordeen; A P Arnold
Journal:  J Comp Neurol       Date:  1989-02-22       Impact factor: 3.215

8.  Hormonal control of a developing neuromuscular system. I. Complete Demasculinization of the male rat spinal nucleus of the bulbocavernosus using the anti-androgen flutamide.

Authors:  S M Breedlove; A P Arnold
Journal:  J Neurosci       Date:  1983-02       Impact factor: 6.167

9.  Lysosomal proliferation and distal degeneration in motor neurons expressing the G59S mutation in the p150Glued subunit of dynactin.

Authors:  Erica S Chevalier-Larsen; Karen E Wallace; Cynthia R Pennise; Erika L F Holzbaur
Journal:  Hum Mol Genet       Date:  2008-03-25       Impact factor: 6.150

10.  Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'.

Authors:  C R Slater; P R W Fawcett; T J Walls; P R Lyons; S J Bailey; D Beeson; C Young; D Gardner-Medwin
Journal:  Brain       Date:  2006-08       Impact factor: 13.501

View more
  16 in total

1.  Selective vulnerability in neuronal populations in nmd/SMARD1 mice.

Authors:  Eric Villalón; Monir Shababi; Rachel Kline; Zachary C Lorson; Kyra M Florea; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2018-02-15       Impact factor: 6.150

Review 2.  Skeletal Muscle Pathogenesis in Polyglutamine Diseases.

Authors:  Caterina Marchioretti; Emanuela Zuccaro; Udai Bhan Pandey; Jessica Rosati; Manuela Basso; Maria Pennuto
Journal:  Cells       Date:  2022-07-03       Impact factor: 7.666

Review 3.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

4.  Pre-clinical symptoms of SBMA may not be androgen-dependent: implications from two SBMA mouse models.

Authors:  Youfen Xu; Katherine Halievski; Masahisa Katsuno; Hiroaki Adachi; Gen Sobue; S Marc Breedlove; Cynthia L Jordan
Journal:  Hum Mol Genet       Date:  2018-07-15       Impact factor: 6.150

5.  Preserving neuromuscular synapses in ALS by stimulating MuSK with a therapeutic agonist antibody.

Authors:  Sarah Cantor; Wei Zhang; Nicolas Delestrée; Leonor Remédio; George Z Mentis; Steven J Burden
Journal:  Elife       Date:  2018-02-20       Impact factor: 8.140

Review 6.  Humanising the mouse genome piece by piece.

Authors:  Fei Zhu; Remya R Nair; Elizabeth M C Fisher; Thomas J Cunningham
Journal:  Nat Commun       Date:  2019-04-23       Impact factor: 14.919

7.  Diaphragm neuromuscular transmission failure in a mouse model of an early-onset neuromotor disorder.

Authors:  Matthew J Fogarty; Joline E Brandenburg; Gary C Sieck
Journal:  J Appl Physiol (1985)       Date:  2020-12-31

8.  NMJ-Analyser identifies subtle early changes in mouse models of neuromuscular disease.

Authors:  Elizabeth M C Fisher; Carole H Sudre; Alan Mejia Maza; Seth Jarvis; Weaverly Colleen Lee; Thomas J Cunningham; Giampietro Schiavo; Maria Secrier; Pietro Fratta; James N Sleigh
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

9.  Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice.

Authors:  Anna L Gray; Leonette Annan; James R T Dick; Albert R La Spada; Michael G Hanna; Linda Greensmith; Bilal Malik
Journal:  Dis Model Mech       Date:  2020-05-26       Impact factor: 5.758

Review 10.  Cell-Clearing Systems Bridging Repeat Expansion Proteotoxicity and Neuromuscular Junction Alterations in ALS and SBMA.

Authors:  Fiona Limanaqi; Carla Letizia Busceti; Francesca Biagioni; Federica Cantini; Paola Lenzi; Francesco Fornai
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.